Antibiotice S.A. Logo

Antibiotice S.A.

ATB | RO

Overview

Corporate Details

ISIN(s):
ROATBIACNOR9
LEI:
315700P5G4O1L6GLMS02
Country:
Romania
Address:
VALEA LUPULUI, 707410 IAȘI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Antibiotice S.A. is a Romanian pharmaceutical company specializing in the research, development, and manufacturing of generic drugs. The company operates eight GMP-certified manufacturing lines, producing a portfolio that includes sterile injectable products and active pharmaceutical ingredients (APIs). It holds U.S. Food and Drug Administration (FDA) approval for key products such as Ampicillin, Nafcillin, and the API Nystatin, demonstrating its commitment to international quality standards. Guided by a mission to make valuable medicines accessible and affordable, Antibiotice serves patients, physicians, and pharmacists in domestic and international markets.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Antibiotice S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-04 12:29
Notice of Dividend Amount
Plata dividend - RC17
Romanian 2.1 MB
2025-08-13 12:27
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-08-06 12:40
Report Publication Announcement
Raport curent de informare a investitorilor
Romanian 137.7 KB
2025-07-24 12:07
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-07-09 12:28
Board/Management Information
Raport curent de informare a investitorilor
Romanian 491.4 KB
2025-07-01 11:49
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 606.7 KB
2025-06-20 14:01
Board/Management Information
Raport curent de informare a investitorilor
Romanian 168.7 KB
2025-06-05 11:06
Regulatory News Service
Raport curent de informare a investitorilor
Romanian 752.7 KB
2025-05-27 15:21
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB
2025-05-26 12:34
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 1.4 MB
2025-05-15 12:05
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 749.5 KB
2025-04-23 11:35
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.6 MB
2025-04-22 15:11
Pre-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 3.9 MB
2025-03-13 07:54
Notice of Dividend Amount
Raport curent de informare a investitorilor
Romanian 688.4 KB
2025-03-13 07:50
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 1.4 MB

Automate Your Workflow. Get a real-time feed of all Antibiotice S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Antibiotice S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Alkaloid AD Logo
Manufacturing pharmaceuticals, cosmetics, and botanicals for consumer and healthcare markets.
North Macedonia ALK
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom AGY
Israel KVSR
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain ALM
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg ALVO
Amphastar Pharmaceuticals Inc. Logo United States of America AMPH
Develops approved cannabinoid medicines for complex, chronic conditions like pain and epilepsy.
United Kingdom N/A
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN
AnGes, Inc. Logo Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR